2 Stocks For a Trump-ed Up Pharma Market

From Stocks To Watch Today
January 11, 2017 - 1:02pm

As my colleague Johanna Bennett noted, comments made by President-elect Donald Trump today about the high prices of drugs, as well as the fact that so many are manufactured outside the U.S. has helped sink biotech and pharmaceutical stocks alike. Those views are likely to remain an overhang for the industry, says Leerink analyst Seamus Fernandez and team, but do think Bristol-Myers Squibb (BMY) and AstraZeneca (AZN) could be relatively insulated. They explain why:



Continue reading this article »